�New technologies will force fundamental alteration in the way health care systems operate. Low-cost cistron sequencing and biopharmaceuticals will make personalized medicine a reality - tailoring the treatment to the patient role. The counterpane of broadband networks makes telemedicine practicable for many, and computerized patient records will transform medical research. New tomography and nosology technologies open the door to more preventative music.
So what will it be wish to be sick in 2020? Who will treat you? How will they get paid? How will health regime decide which new technologies are worth the money?
These are among the pressing questions to be examined at an external gathering of research, industry and policy experts Nov. 6, organized by UCL Advances, UCL's centre for entrepreneurship and business interaction, and the Science|Business intelligence service. The conference will draw on expertise from all the new technology strands - bioinformatics, imagination, diagnostics, devices, biopharmaceuticals and more - to make a composite plant picture of the patient role experience in 2020, and to talk about what healthcare authorities should be doing now to prepare for that day. The outcomes will include a survey and extra report summarizing the unexampled scenarios - plus expert recommendations for action.
The conference is a joint venture between UCL Advances and Science Business Publishing Ltd., a UK-based media company focused on R&D investment and policy across Europe. Learn more around the league by visiting the site here.
About Science Business
Science Business Publishing Ltd. is a London-based media company focused on R&D investment in Europe. It reports news daily online and in a weekly newsletter, and organizes events to convey together public-sector researchers, bodied partners and policy makers. It was founded in 2005 by the former managing editors of the Wall Street Journal Europe and preeminent science journal Nature, and works with a network of 10 leading European research universities, including UCL.
Science Business
More information
